Featured

Transforming pharmacy practice for improved care and management of cancer



Published
Cancer is the second leading cause of death globally, according to the World Health Organization. Prevention and early screening are crucial elements of interprofessional strategies to reduce the burden, morbidity and mortality associated with cancer, as are medication management for optimal outcomes, and patient support. Pharmacists have a key role to play in all these areas. At this digital event, FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of cancer-related services. In addition, the handbook will be accompanied by the knowledge and skills (K&S) reference guide in cancer which identifies the K&S that pharmacists require for the provision of such services, thus offering guidance to pharmacists, academic institutions and CPD providers. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.



Attendees will learn about:


1. The role of pharmacists in the prevention, screening, care and management of cancer;
2. Challenges and opportunities for pharmacists in implementing cancer-related services;
3. The knowledge and skills pharmacists need to acquire to support their role in the delivery of cancer-related services.


Moderator:


-Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP Portugal


Panelists:
-Evelyn Handel, ISOPP President (2022-2024) International Society of Oncology Pharmacy Practitioners (ISOPP) - USA
-Folakemi T. Odedina, Professor of Oncology Mayo Clinic Cancer Center - USA
-Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre -Canada
-Dalia Bajis, Lead for provision and partnerships FIP Australia
Category
Health
Be the first to comment